Top Markets
Coin of the day
GemVax&KAEL Co.,Ltd GemVax&KAEL Co.,Ltd

GemVax&KAEL Co.,Ltd

082270
Classement en actions #15776
GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration... GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration systems and gas purification units, primarily for the semiconductor industry. The company operates through two main segments: Environmental Pollution Control and Bio Business. Its Environmental Pollution Control division focuses on creating essential filters for semiconductor and display fabrication processes, in addition to developing equipment for air quality management and odor prevention. Concurrently, the Bio Business division is dedicated to advancing its innovative telomerase-derived peptide drug, GV1001, through preparations for domestic and international Phase 2 and 3 clinical trials. These trials are designed to address various conditions, including Alzheimer's disease, benign prostatic hyperplasia, and progressive supranuclear palsy. Founded on March 10, 1998, GemVax & KAEL Co., Ltd. is headquartered in Daejeon, South Korea.
Prix de l'action
$7.54
Capitalisation boursière
$331.60M
Changement (1 jour)
-3.79%
Changement (1 an)
-75.66%
Pays
KR
Échange GemVax&KAEL Co.,Ltd (082270)

Catégorie

Ratio P/B pour GemVax&KAEL Co.,Ltd (082270)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de GemVax&KAEL Co.,Ltd, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour GemVax&KAEL Co.,Ltd de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
- -
US
3.2386 -
DE
- -
FR
- -
DE
8.0179 -
US